Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
PHILADELPHIA, May 27, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds announced they each held their Annual Meeting of Shareholders (the "Meetings") on May 27, 2026. At the Meetings, shareholders of the respective Funds voted on the proposals set forth below: abrdn Asia-Pacific Income Fund, Inc. ("FAX")As of the record date, April 1, 2026, FAX had outstanding 45,282,628 shares of common and preferred stock. 74.60% of outstanding common and preferred stock were voted representing a quorum.To elect one Class II Director to the Board of Directors:Vot
PHILADELPHIA, May 11, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on May 29, 2026 to all shareholders of record as of May 21, 2026 (ex-dividend date May 21, 2026). The abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), and the India Fund, Inc. (IFN) will pay their distributions on June 30, 2026, to shareholders of record as of May 21, 2026 (ex‑dividend date May 21, 2026).
PHILADELPHIA, March 31, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF) (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on March 31, 2026, on a per share basis to all shareholders of record as of March 24, 2026 (ex-dividend date March 24, 2026). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and Aberdeen India Fund Inc. (IFN) which paid on March 31, 2026, to all shareholders of record as of February 20, 2026 (ex-dividend date Fe
3 - abrdn Life Sciences Investors (0000884121) (Issuer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
4 - abrdn Life Sciences Investors (0000884121) (Issuer)
N-CSR - abrdn Life Sciences Investors (0000884121) (Filer)
N-CEN - abrdn Life Sciences Investors (0000884121) (Filer)
N-PX - abrdn Life Sciences Investors (0000884121) (Filer)
SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)
SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)
SC 13D/A - abrdn Life Sciences Investors (0000884121) (Subject)
PHILADELPHIA, May 27, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds announced they each held their Annual Meeting of Shareholders (the "Meetings") on May 27, 2026. At the Meetings, shareholders of the respective Funds voted on the proposals set forth below: abrdn Asia-Pacific Income Fund, Inc. ("FAX")As of the record date, April 1, 2026, FAX had outstanding 45,282,628 shares of common and preferred stock. 74.60% of outstanding common and preferred stock were voted representing a quorum.To elect one Class II Director to the Board of Directors:Vot
PHILADELPHIA, May 11, 2026 /PRNewswire/ -- The following Aberdeen Investments U.S. Closed-End Funds (NYSE:ACP, AGD, AOD, ASGI, AWP, HQH, HQL, IFN, THQ, NYSE:FAX, IAF, VFL)), announced today that the closed end funds in the chart directly below will pay the distributions indicated on a per share basis on May 29, 2026 to all shareholders of record as of May 21, 2026 (ex-dividend date May 21, 2026). The abrdn Healthcare Investors (HQH), the abrdn Life Sciences Investors (HQL), the abrdn Australia Equity Fund, Inc. (IAF), and the India Fund, Inc. (IFN) will pay their distributions on June 30, 2026, to shareholders of record as of May 21, 2026 (ex‑dividend date May 21, 2026).
PHILADELPHIA, March 31, 2026 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, THQ)), (NYSE:IAF) (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in the table below on March 31, 2026, on a per share basis to all shareholders of record as of March 24, 2026 (ex-dividend date March 24, 2026). These dates apply to the Funds listed below with the exception of abrdn Healthcare Investors (HQH), abrdn Life Sciences Investors (HQL), abrdn Australia Equity Fund, Inc. (IAF) and Aberdeen India Fund Inc. (IFN) which paid on March 31, 2026, to all shareholders of record as of February 20, 2026 (ex-dividend date Fe
PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") each, a closed-end management investment company, announced today the appointment of Dr. Jason Akus as co-lead portfolio manager to the Funds alongside Dr. Daniel Omstead. Dr. Akus has served on the investment team with Dr. Omstead for over 20 years.The Funds will continue to be managed in accordance with their existing investment objectives and strategies, pursuing the same investment philosophy and employing the same investment process that has